Lack of research preventing wider prescribing of cannabis for arthritis

Lack of research preventing wider prescribing of cannabis for arthritis
Cannabis Health News

A lack of research is preventing wider uptake of medical cannabis prescribing for arthritis pain, according to a new review published in the US. A new review article has found that there has been limited progress in understanding the potential of cannabis-based therapies for the treatment of pain associated with rheumatic conditions in the past five years. The article concluded that this is primarily due to a lack of standardisation of clinical research and barriers to conducting research due to existing federal and state regulations in the US. The review, which was published by CreakyJoints, an international digital community for arthritis patients and caregivers, found that the legalisation and decriminalisation of cannabis at a state level in the US reflects changing attitudes about cannabis as use of the drug increases across a broad range of conditions, including rheumatic diseases. Unfortunately, while there is strong preclinical evidence showing that cannabis-based products play a role in alleviating pain and reducing inflammation, the highly variable state and federal statutes have limited patient-centred prospective research, education of clinicians and comfort of patients in disclosing their cannabis use to clinicians. W. Benjamin Nowell, PhD, director of patient-Centered research at CreakyJoints said: “In 2019, CreakyJoints presented data from our ArthritisPower Research Registry study showing more than half of arthritis patients reported wanting information on or actually had tried cannabis and/or cannabidiol products for a purpose they perceived as medical – often for pain relief and help sleeping. “Yet, three years later, there’s been virtually no advancement in the research necessary to provide clinical evidence that rheumatologists and patients need to make decisions about cannabis use for symptom relief in combination with approved treatments.” He added: “Without this research, it is impossible to develop clinical guidelines for medicinal cannabis in the US, which is vital for patients…

Excerpt only …
READ MORE BELOW
Source : Lack of research preventing wider prescribing of cannabis for arthritis

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.